Episode Details

Join in, to hear Dr. Ruth Cheng, CEO share her vision for ATCC’s future, emphasizing the need for organizational agility, calculated risk-taking, and alignment with the pace of scientific progress. She highlights recent initiatives like the partnership with Align to Innovate to develop digital data reference standards and outlines plans to expand ATCC’s global footprint. Dr. Cheng discusses investments in cutting-edge technologies such as microphysiological systems, single-cell sequencing, and high-resolution imaging. Reflecting on her legacy, she expresses a desire to ensure ATCC remains mission-driven and relevant for the next century, while encouraging future leaders to embrace challenges and stay grounded in their values.